Why the study?
Does elevated baseline CRP (>3 mg/l) increase the risk of incident coronary heart disease and ischemic stroke in an elderly population (≥65 years)?
Does elevated baseline CRP (>3 mg/l) increase the risk of incident coronary heart disease and ischemic stroke in an elderly population (≥65 years)?
In an elderly population, elevated baseline CRP (>3 mg/L) is associated with an increased 8-year risk of incident coronary heart disease and ischemic stroke, independent of sex or race.
No takes yet. Share an insight, caveat, or question.
Elevated CRP may aid risk stratification in adults ≥65; leaves open whether measurement or targeting improves outcomes.
Xia Li (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: